Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation

Shijia Zhang,Ryan Shanley,Daniel J Weisdorf,Armin Rashidi

Blood Advances（2020）

引用 4|浏览13

暂无评分

摘要

Key Points Vancomycin exposure in the pre-engraftment period was associated with an increased risk for CMV reactivation after allogeneic HCT. Some gram-positive bacteria may protect against CMV reactivation.

查看译文

关键词

cytomegalovirus reactivation,allogeneic hematopoietic cell transplantation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要